ArticleArthritis and rheumatism2011

The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.

Hideharu Sekine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.